Journal Article

DZNE-2026-00472

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Long-read sequencing identifies FGF14 repeat expansions in Parkinson's disease.

Akçimen, F. ; Daida, K. ; Lange, L. M. ; Moller, A. ; Miano-Burkhardt, A. ; Malik, L. ; Paquette, K. ; Alvarez Jerez, P. ; Mingle, J. ; Baker, B. ; Meredith, M. ; Kouam, C. ; Jarreau, P. ; Markham, A. ; Anderson, J. ; Jain, M. ; Chaisson, M. ; Cookson, M. ; Casey, B. ; Iwaki, H. ; Bandres-Ciga, S. ; Saffie-Awad, P. ; Nalls, M. A. ; Fang, Z.-H.DZNE* ; Singleton, A. B. ; Blauwendraat, C. ; Billingsley, K. J.

2026
Oxford Univ. Press Oxford

This record in other databases:    

Please use a persistent id in citations: doi:10.1093/brain/awaf456

Abstract: Pathogenic GAA repeat expansions in FGF14 are an established cause of late-onset cerebellar ataxia, but have not been linked to Parkinson's disease. Given emerging evidence that repeat expansions in ataxia-associated genes like RFC1 can contribute to atypical or familial forms of Parkinson's disease, we investigated whether FGF14 expansions might play a similar role. Using long-read whole-genome sequencing, we analysed 411 individuals with Parkinson's disease and 197 neurologically healthy controls from the Parkinson's Progression Markers Initiative (PPMI) cohort, together with 1429 additional controls from the National Institutes of Health (NIH) Center for Alzheimer's Disease and Related Dementias (CARD) initiative, the 1000 Genomes Project, and the All of Us program, representing globally diverse populations. We identified pathogenic FGF14 GAA repeat expansions in five individuals with Parkinson's disease and one control subject. All five individuals fit the clinical criteria of Parkinson's disease and showed typical patterns of neurodegeneration on DaTSCAN imaging; α-synuclein aggregation was confirmed by a positive seeding assay among four individuals with available data. These findings broaden the phenotypic spectrum of FGF14 repeat-associated disease and suggest a rare, previously unrecognized genetic contributor to Parkinson's disease. To our knowledge, this is the first report implicating FGF14 in Parkinson's disease and underscores the utility of long-read sequencing for detecting hidden forms of pathogenic variation in unresolved cases.

Keyword(s): Humans (MeSH) ; Parkinson Disease: genetics (MeSH) ; Parkinson Disease: diagnostic imaging (MeSH) ; Male (MeSH) ; Female (MeSH) ; Aged (MeSH) ; Fibroblast Growth Factors: genetics (MeSH) ; Middle Aged (MeSH) ; Trinucleotide Repeat Expansion: genetics (MeSH) ; Whole Genome Sequencing (MeSH) ; alpha-Synuclein: metabolism (MeSH) ; Cohort Studies (MeSH) ; Aged, 80 and over (MeSH) ; FGF14 ; Parkinson’s disease ; long-read sequencing ; short tandem repeats ; Fibroblast Growth Factors ; fibroblast growth factor 14 ; alpha-Synuclein

---

Contributing Institute(s):

1. Parkinson Genetics (AG Gasser)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2026

---

Database coverage:
; ; ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; Ebsco Academic Search ; Essential Science Indicators ; IF >= 10 ; JCR ; Nationallizenz ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection

---